HTH Health Technology Holding

HTH Health Technology Holding is a private venture capital firm based in Milan, Italy, specializing in early to mid-stage investments in life science companies. The firm focuses on breakthrough technologies in biotech, medtech, and digital health sectors, aiming to support innovations that improve human health.

Established in 2020, HTH complements ZCube-Zambon Research Venture's activities by directly participating in early-stage deep tech startups. The firm's investment strategy emphasizes collaboration with innovators dedicated to enhancing human health through technological advancements.

HTH's portfolio includes companies like Lys Therapeutics, a biotechnology firm developing treatments for neurovascular and neurodegenerative disorders. The firm's approach reflects a commitment to addressing significant health challenges through strategic investments in promising life science ventures.